P3 Health Partners Revenue 2020-2024 | PIII

P3 Health Partners revenue from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
P3 Health Partners Annual Revenue
(Millions of US $)
2024 $1,500
2023 $1,266
2022 $1,049
2021 $637
2020 $491
2019 $145
P3 Health Partners Quarterly Revenue
(Millions of US $)
2024-12-31 $371
2024-09-30 $362
2024-06-30 $379
2024-03-31 $388
2023-12-31 $347
2023-09-30 $288
2023-06-30 $329
2023-03-31 $302
2022-12-31 $258
2022-09-30 $248
2022-06-30 $269
2022-03-31 $274
2021-12-31 $185
2021-09-30 $156
2021-06-30 $145
2021-03-31 $151
2020-12-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.057B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.499B 54.56
Hims & Hers Health (HIMS) United States $14.471B 150.35
Tempus AI (TEM) United States $11.278B 0.00
Inspire Medical Systems (INSP) United States $4.503B 70.35
IRhythm Technologies (IRTC) United States $4.501B 0.00
Privia Health (PRVA) United States $3.050B 208.50
Enovis (ENOV) United States $2.060B 11.48
Clover Health Investments (CLOV) United States $1.807B 0.00
Schrodinger (SDGR) United States $1.722B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.310B 23.11
Azenta (AZTA) United States $1.258B 58.45
10x Genomics (TXG) United States $1.148B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.455B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.376B 834.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.142B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.089B 3.39
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.067B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.042B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00